title: When is it safe to stop for safety?
authors.forename: S
authors.initials: S
authors.lastname: Schulman
authors.forename: A
authors.initials: A
authors.lastname: Carlsson
authors.forename: S
authors.initials: S
authors.lastname: Laporte
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects*; D002423:Cause of Death; D026661:Clinical Trials Data Monitoring Committees / Q000592:standards; D017326:Clinical Trials, Phase III as Topic / Q000379:methods* / Q000592:standards; D057239:Early Termination of Clinical Trials; D019317:Evidence-Based Medicine; D006470:Hemorrhage / Q000139:chemically induced* / Q000401:mortality; D006801:Humans; D061214:Patient Safety / Q000592:standards; D017410:Practice Guidelines as Topic; D012008:Recurrence; D012107:Research Design / Q000592:standards; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome; D054556:Venous Thromboembolism / Q000188:drug therapy* / Q000401:mortality
chemical_list: D000925:Anticoagulants